Clinical trial
Collection of Patients' Background InformationRelenza® Sentinel Site Monitoring Program in Japan
NCT01199744 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Collection of Patients' Background InformationRelenza® Sentinel Site Monitoring Program in Japan
- Lead sponsor
- GlaxoSmithKline
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- April 30, 2010
- Enrollment
- 1,575 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.